Combination provides enhanced services for hospitals, physicians and
patients of both companies
NASHVILLE, Tenn.–(BUSINESS WIRE)–PathGroup,
one of the largest private providers of pathology, clinical and
molecular laboratory services in the United States, today announced that
it has acquired Pathologists
Bio-Medical Laboratories (PBM), a leading provider of pathology
services based in Dallas.
The combination of Nashville-based PathGroup and PBM will lead to
enhanced services and a broader menu of testing across their client
base. The combined company will include more than 120 pathologists,
representing every sub-specialty, creating one of the most comprehensive
pathology networks in the country.
“This joining of forces expands PathGroup’s presence in one of our key
markets, while also providing a platform of enhanced services for the
current clients and patients of both companies,” said Ben W. Davis,
M.D., President and Chief Executive Officer of PathGroup. “The
dedication of PBM to their community, clients and patients, their
culture of physician leadership, and their goal of providing
state-of-the-art services all match PathGroup’s commitments and values.
Both companies have provided superior pathology services for more than
50 years. We look forward to working with the industry-leading health
systems and practices of PBM to continue providing these services.”
“PBM and PathGroup have similar histories of providing high-quality
pathology services to patients, physicians and health systems,” said
Peter A. Dysert, M.D., President of PBM. “Our like-minded cultures of
physician leadership and private ownership will allow us to focus on
what is best for the clients and patients we serve. We look forward to
working with PathGroup and continuing to exceed the expectations of our
hospitals and physician clients.”
The combined company will be comprised of more than 1,800 employees
working with more than 75 hospitals and thousands of physicians across
the U.S. to deliver quality lab testing and diagnostic results with
unmatched responsiveness.
About PathGroup
Founded in 1965, PathGroup is a premier provider of anatomic, clinical
and molecular pathology services in the United States. Privately held
and physician-centric, PathGroup works seamlessly with customers to
provide superior diagnostic services – a vital link in the cycle of
patient relationships. PathGroup uses the latest in proprietary and
industry standard technology to deliver fast, accurate results. The
company provides clients with the highest quality of services available,
consistently exceeding the expectations of physicians, employees,
payers, and most importantly, patients. One Lab; Total Service.
PathGroup is owned by Pritzker Private Capital along with management.
For more information, visit pathgroup.com.
About Pritzker Private Capital
Pritzker Private Capital acquires and operates middle-market companies
based in North America with leading positions in the manufactured
products, services and healthcare sectors. The firm’s differentiated,
long-duration capital base allows for efficient decision-making, broad
flexibility with transaction structure and investment horizon, and
alignment with all stakeholders. Pritzker Private Capital builds
businesses for the long term and is an ideal partner for entrepreneur
and family owned companies. For more information, visit PPCPartners.com.
Contacts
PathGroup Corporate:
Richard A. Halstead
EVP, Chief Commercial
Officer
615-234-3915
[email protected]
